Tafenoquine Succinate Patent Expiration
Tafenoquine Succinate is used for preventing malaria in adults through a three-phase dosing regimen. It was first introduced by Glaxosmithkline Intellectual Property Development Ltd England
Tafenoquine Succinate Patents
Given below is the list of patents protecting Tafenoquine Succinate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Arakoda | US10342791 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | Dec 02, 2035 | 60 Degrees Pharms |
| Arakoda | US10888558 | Regimens of tafenoquine for prevention of malaria in malaria-naive subjects | Dec 02, 2035 | 60 Degrees Pharms |
| Arakoda | US11744828 | Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects | Dec 02, 2035 | 60 Degrees Pharms |
Tafenoquine Succinate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List